Table 2.

Comparison of functional outcomes between baseline and two-year follow-up visits

	Control (N = 20)		T2DM (N = 20)
Visit	Baseline	2 years	Baseline	2 years
Vasoreactivity (mL/100 g/min/mmHg)
Global	0.95 ± 0.57	0.69 ± 0.45	1.33 ± 1.07	0.72 ± 0.42‡
Frontal	0.83 ± 0.58	0.62 ± 0.46	1.17 ± 0.86	0.69 ± 0.50‡
Parietal	1.06 ± 0.75	0.82 ± 0.52	1.33 ± 0.83	0.88 ± 0.57
Temporal	0.89 ± 0.53	0.62 ± 0.39	1.17 ± 0.72	0.68 ± 0.35‡
Occipital	1.31 ± 0.91	1.02 ± 0.56	1.52 ± 0.84	1.02 ± 0.71
Gait measures
Normal walking (m/s)	1.16 ± 0.18	1.16 ± 0.13	1.05 ± 0.14§,	1.16 ± 0.30
Dual-task walking (m/s)	1.04 ± 0.52†	1.05 ± 0.15†	0.97± 0.19	1.05 ± 0.33†
Dual-task cost (%)	8.93 ± 10.32	9.41 ± 7.01	6.44 ± 17.35	10.09 ± 11.50

^*Comparison between normal walking and dual-task walking (two-tailed matched pairs), if p < 0.05;

^†if p < 0.01

^‡Comparison between baseline and two-year follow-up visits (one-tailed matched pairs), if p < 0.05

^§Between-group comparison (ANOVA), if p < 0.05